4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-047820
Chief Financial Officer sold 1,496 shares at $12.09 ($18,087)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2020-08-18 | Sale | −1,496 | $12.09 | $18,087 | 133,530 | D |
| Open-market sales · 1,496 sh · avg $12.09 · $18,087 | |||||||
Loading xslF345X03/doc4.xml…